KKKaren L. Kaul

Karen L. Kaul

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Karen L. Kaul has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Kathy A. Mangold

    Department of Pathology, Endeavor Health, Evanston, IL 60201, USA

    5 shared publications
  • Aamair M. Tajuddin

    Department of Pathology and Laboratory Medicine,1 Center on Outcomes, Research and Education,2 Evanston Northwestern Healthcare, Evanston, Illinois; Department of Pharmacology, University of Colorado Health Science Center, Denver, Colorado,3 Department of Pathology and Laboratory Medicine, Children's Memorial Hospital, Chicago, Illinois,4 Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois5

    2 shared publications
  • Jeffrey M. Barrett

    Interdepartmental Biological Sciences Program, Northwestern University, Evanston, Illinois 60201, USA

    2 shared publications
  • MaryAnn Regner

    Department of Pathology and Laboratory Medicine,1 Center on Outcomes, Research and Education,2 Evanston Northwestern Healthcare, Evanston, Illinois; Department of Pharmacology, University of Colorado Health Science Center, Denver, Colorado,3 Department of Pathology and Laboratory Medicine, Children's Memorial Hospital, Chicago, Illinois,4 Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois5

    2 shared publications
  • Mohammed Tajuddin

    Department of Pathology and Laboratory Medicine,1 Center on Outcomes, Research and Education,2 Evanston Northwestern Healthcare, Evanston, Illinois; Department of Pharmacology, University of Colorado Health Science Center, Denver, Colorado,3 Department of Pathology and Laboratory Medicine, Children's Memorial Hospital, Chicago, Illinois,4 Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois5

    2 shared publications
  • Richard B. Thomson

    Department of Pathology and Laboratory Medicine, Evanston Northwestern Healthcare and Northwestern University Feinberg School of Medicine, Evanston, Illinois

    2 shared publications

Latest Publications

  • Neisseria Species Identification Assay for the Confirmation of Neisseria gonorrhoeae -Positive Results of the COBAS Amplicor PCR

    by Kathy A. Mangold, MaryAnn Regner, Mohammed Tajuddin, Aamair M. Tajuddin, Lawrence Jennings, Hongyan Du, Karen L. Kaul

    Screening assays for Neisseria gonorrhoeae exhibit low positive predictive values, particularly in low-prevalence populations. A new real-time PCR assay that detects and identifies individual Neisseria spp. using melt curve analysis was compared to two previously published supplementary assays. NsppID, a 16S rRNA real-time PCR/melt curve assay developed to distinguish N. gonorrhoeae from other Neisseria spp., was compared to real-time PCR assays targeting genes reportedly specific for N. gonorrhoeae , the cppB gene and the porA pseudogene. A total of 408 clinical specimens (324 female endocervical swabs and 84 male urine or urogenital swab specimens) were screened using the COBAS Amplicor assay for Chlamydia trachomatis and N. gonorrhoeae (CT/NG) (Roche Diagnostics, Indianapolis, IN) followed by confirmatory testing via real-time PCR. The NsppID assay detected Neisseria spp. in 150/181 COBAS-positive specimens (82%), including six dual infections, and identified N. gonorrhoeae in 102 (56%) specimens. Sixty-nine of 181 (38%) specimens were positive for N. gonorrhoeae by porA pseudogene, and 115/181 (64%) were positive for cppB . However, cppB was also positive in 15% of COBAS-negative specimens, more than either NsppID (4%) or porA pseudogene (2%) assays. The porA pseudogene assay had the highest specificity for both genders but the lowest sensitivity, especially in female specimens. NsppID had a slightly lower specificity but greater sensitivity and overall accuracy. The least desirable confirmatory assay was cppB , due to poor specificity. The NsppID assay is an accurate confirmatory assay for N. gonorrhoeae detection. In addition, the NsppID assay can identify the non- N. gonorrhoeae species responsible for the majority of false-positive results from the COBAS Amplicor CT/NG assay.


  • Prostate cancer cells regulate growth and differentiation of bone marrow endothelial cells through TGFβ and its receptor, TGFβRII

    by Jeffrey M. Barrett, Mark A. Rovedo, Aamair M. Tajuddin, Tamas Jilling, Jill A. Macoska, James MacDonald, Kathy A. Mangold, Karen L. Kaul

    BACKGROUND The underlying mechanisms permitting prostate cancer bone metastasis are poorly understood. We previously showed that the highly metastatic prostate cancer cell line, PC-3, inhibits bone marrow endothelial (HBME-1) cell growth in collagen gels and induces them to differentiate into cords, resembling angiogenesis in vivo. METHODS cDNA microarray analysis was performed to identify cytokines responsible for the effects of PC-3 cells on HBME-1 cells. Cytokine and neutralizing antibody studies were done to further investigate specific angiogenic factors, such as transforming growth factor β (TGFβ). TGFβ RNA and protein were detected by real-time RT-PCR and enzyme-linked immunosorbent assay (ELISA) analysis to measure their production by prostate cancer cell lines. Conditioned media experiments using TGFβ neutralizing antibodies were used to analyze TGFβ activation by prostate cancer cells. RESULTS PC-3 conditioned media altered the expression of several TGFβ-regulated or -associated genes in HBME-1 cells. Low concentrations of TGFβ cytokines inhibited HBME-1 cell growth to a similar level as PC-3 conditioned media and partially induced differentiation. Inhibitors and neutralizing antibodies directed against TGFβ isoforms and TGFβ receptor type 2 (TGFβRII) reversed the growth inhibition of HBME-1 cells conferred by PC-3 conditioned media. Yet, only TGFβRII neutralizing antibodies significantly inhibited HBME-1 differentiation. Also, prostate cancer cell lines produced low levels of TGFβ RNA and protein, and were shown to activate serum-derived TGFβ. CONCLUSIONS These results suggest that prostate cancer cells mediate growth inhibition and differentiation of bone marrow endothelial cells both through production and activation of TGFβ as well as alteration of TGFβRII-mediated signal transduction. This could contribute to the establishment and growth of bone metastases. Prostate 66:632–650, 2006.


  • Open Access

    Species-Level Identification of Staphylococcal Isolates by Real-Time PCR and Melt Curve Analysis

    by Áine Skow, Kathy A. Mangold, Mohammed Tajuddin, Anne Huntington, Brett Fritz, Richard B. Thomson, Karen L. Kaul

    A real-time PCR assay was developed to identify common staphylococcal species. A single set of consensus primers was designed to amplify a portion of the 16S rRNA gene, and a pair of fluorescence resonance energy transfer probes was used to identify species based on the unique melt properties of the probes resulting from sequence variations in the amplicons from each species. Nine common staphylococcal strains (S. aureus,S. capitis,S. epidermidis,S. haemolyticus,S. hominis,S. lugdunensis,S. schleiferi,S. simulans, andS. warneri) were used for assay development. The species-specific melting profiles were validated by correctly identifying 36 of 37 coagulase-negative staphylococcal (CoNS) isolates identified by ribotyping. In a study of clinical isolates, the PCR/melt curve approach correctly identified 56/56S. aureusisolates identified by coagulase/protein A latex agglutination. Fifty-four CoNS clinical isolates characterized using the API Staph assay were studied, with the PCR/melt curve approach yielding matching identifications for 32/54 (59%). The API Staph assay was unable to identify 18 CoNS isolates, and differing results were obtained for 4 isolates. Sequencing of the 22 discrepant or unidentified CoNS samples revealed that the PCR/melt curve results were correct for all but one isolate. Thus, PCR/melt curve analysis achieved a nearly 100% accuracy and performed better than biochemical testing. Performance of the PCR/melt curve approach requires less than 2 h after colony selection. This method thus provides a rapid and accurate approach to the identification of staphylococcal species in the clinical laboratory.


  • Open Access

    Real-Time PCR for Detection and Identification of Plasmodium spp

    by Kathy A. Mangold, Rebecca U. Manson, Evelyn S. C. Koay, Lindsey Stephens, MaryAnn Regner, Richard B. Thomson, Lance R. Peterson, Karen L. Kaul

    Rapid and accurate detection of malaria parasites in blood is needed to institute proper therapy. We developed and used a real-time PCR assay to detect and distinguish four Plasmodium spp. that cause human disease by using a single amplification reaction and melting curve analysis. Consensus primers were used to amplify a species-specific region of the multicopy 18S rRNA gene, and SYBR Green was used for detection in a LightCycler instrument. Patient specimens infected at 0.01 to 0.02% parasitemia densities were detected, and analytical sensitivity was estimated to be 0.2 genome equivalent per reaction. Melting curve analysis based on nucleotide variations within the amplicons provided a basis for accurate differentiation of Plasmodium falciparum , P. vivax , P. ovale , and P. malariae . For assay validation, 358 patient blood samples from the National University Hospital in Singapore and Evanston Northwestern Healthcare in Illinois were analyzed. Of 76 blinded patient samples with a microscopic diagnosis of P. falciparum , P. vivax , or P. ovale infection, 74 (97.4%) were detected by real-time PCR, including three specimens containing mixed P. falciparum - P. vivax infections. No Plasmodium DNA was amplified in any of the 82 specimens sent for malaria testing but that were microscopically negative for Plasmodium infection. In addition, 200 blood samples from patients whose blood was collected for reasons other than malaria testing were also determined to be negative by real-time PCR. Real-time PCR with melting curve analysis could be a rapid and objective supplement to the examination of Giemsa-stained blood smears and may replace microscopy following further validation.


  • Bi‐directional interactions of prostate cancer cells and bone marrow endothelial cells in three‐dimensional culture

    by Jeffrey M. Barrett, Kathy A. Mangold, Tamas Jilling, Karen L. Kaul

    BACKGROUND: Prostate cancer preferentially metastasizes to bone, yet little is known about the cellular and molecular factors that support this growth. Endothelial cells are likely the initial contact for circulating prostate cells entering the bone microenvironment.METHODS: Using co‐culture and conditioned media experiments, we studied cellular and molecular interactions of prostate cancer cells of varying aggressiveness (PC‐3 and LNCaP) with bone marrow endothelial (HBME‐1) cells in collagen gels.RESULTS: In co‐culture, HBME‐1 cells stimulated proliferation (∼90% increase) and migration of the more aggressive PC‐3 cell line, while having little effect on LNCaP cell proliferation or migration. Concomitantly, HBME‐1 cell growth was inhibited by both PC‐3 and LNCaP cells and their conditioned media. Additionally, HBME‐1 cells underwent significant morphological changes in co‐culture, forming large, branching, cord‐like structures, which mimic angiogenesis. Prostate cancer cell conditioned media induced a similar effect on HBME‐1 cells. In comparison, conditioned media from PC‐3 cells also inhibited growth of non‐bone marrow‐derived endothelial cells, but did not affect their morphology.CONCLUSIONS: Significant bi‐directional interactions, including secreted factors and direct cellular interactions, exist between bone marrow endothelial cells and highly metastatic prostate cancer cells, and may underlie the propensity for prostate cancer to metastasize to the bone.